Abstract

BackgroundThe OMERACT rheumatoid arthritis (RA) magnetic resonance imaging (MRI) scoring system (RAMRIS) is a validated system for assessment of synovitis, bone edema and bone erosion. Previous studies have reported that...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16
L T H Jacobsson ... C Schaufelberger
Annals of the Rheumatic Diseases | VOL. 74
L T H Jacobsson, et. al.L T H Jacobsson ... C Schaufelberger
15 Dec 2014
Comparative analysis of low-field magnetic resonance imaging in patients with rheumatoid arthritis treated with certolizumab pegol or infliximab.
Mizuki Yagishita ... Fumika Honda
Modern rheumatology | VOL. 33
Mizuki Yagishita, et. al.Mizuki Yagishita ... Fumika Honda
28 Nov 2022
FRI0044 Exceeding predefined thresholds for mri bone oedema and erosion and haq-di can predict relapse after withdrawal of all treatment in mtx-naÏve patients with ra in remission after 12 months of abatacept therapy in the avert trial
J.F Baker ... P.G Conaghan
Annals of the Rheumatic Diseases | VOL. 77
J.F Baker, et. al.J.F Baker ... P.G Conaghan
01 Jun 2018
Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis.
Fiona M Mcqueen ... Lachy Mclean
Arthritis and rheumatism | VOL. 48
Fiona M Mcqueen, et. al.Fiona M Mcqueen ... Lachy Mclean
01 Jul 2003
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers